ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,402,000 | +28.1% | 19,760 | -6.6% | 0.11% | +25.0% |
| Q2 2021 | $2,656,000 | -24.2% | 21,160 | -18.1% | 0.09% | -29.0% |
| Q1 2021 | $3,503,000 | +3.9% | 25,836 | -1.9% | 0.12% | +7.8% |
| Q4 2020 | $3,370,000 | -10.5% | 26,336 | -21.3% | 0.12% | -6.5% |
| Q3 2020 | $3,765,000 | +220.7% | 33,456 | +171.5% | 0.12% | +284.4% |
| Q2 2020 | $1,174,000 | +83.2% | 12,324 | +72.9% | 0.03% | +68.4% |
| Q1 2020 | $641,000 | – | 7,127 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |